| 000 | 01399 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512010754.0 | ||
| 264 | 0 | _c19900131 | |
| 008 | 199001s 0 0 eng d | ||
| 022 | _a0026-895X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, C W | |
| 245 | 0 | 0 |
_aDistinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33). _h[electronic resource] |
| 260 |
_bMolecular pharmacology _cDec 1989 |
||
| 300 |
_a881-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzodiazepinones _xpharmacology |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCholecystokinin _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDevazepide |
| 650 | 0 | 4 | _aGastrins |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
| 650 | 0 | 4 |
_aProglumide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aReceptors, Cholecystokinin _xdrug effects |
| 650 | 0 | 4 |
_aTetragastrin _xanalogs & derivatives |
| 700 | 1 | _aHolladay, M W | |
| 700 | 1 | _aBarrett, R W | |
| 700 | 1 | _aWolfram, C A | |
| 700 | 1 | _aMiller, T R | |
| 700 | 1 | _aWitte, D | |
| 700 | 1 | _aKerwin, J F | |
| 700 | 1 | _aWagenaar, F | |
| 700 | 1 | _aNadzan, A M | |
| 773 | 0 |
_tMolecular pharmacology _gvol. 36 _gno. 6 _gp. 881-6 |
|
| 999 |
_c2607583 _d2607583 |
||